| 000 | 01785 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513084525.0 | ||
| 264 | 0 | _c19960304 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.1995.tb16623.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPestana, M | |
| 245 | 0 | 0 |
_aAssessment of renal dopaminergic system activity during cyclosporine A administration in the rat. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cAug 1995 |
||
| 300 |
_a1349-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAromatic-L-Amino-Acid Decarboxylases _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase _xmetabolism |
| 650 | 0 | 4 |
_aCreatinine _xmetabolism |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aKidney Cortex _xdrug effects |
| 650 | 0 | 4 |
_aKidney Tubules _xdrug effects |
| 650 | 0 | 4 |
_aLevodopa _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 650 | 0 | 4 |
_aUrea _xmetabolism |
| 700 | 1 | _aVieira-Coelho, M A | |
| 700 | 1 | _aPinto-do-O, P C | |
| 700 | 1 | _aFernandes, M H | |
| 700 | 1 | _aSoares-da-Silva, P | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 115 _gno. 8 _gp. 1349-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.1995.tb16623.x _zAvailable from publisher's website |
| 999 |
_c8563262 _d8563262 |
||